MGI Tech Joins Forces with Dasa to Enhance Precision Medicine in Brazil Through Advanced Genomic Sequencing

MGI Tech Co., Ltd, a leading gene sequencing company based in China, has announced a strategic collaboration with Dasa, Latin America’s largest medical diagnostics company. This partnership aims to integrate Dasa’s extensive patient service network with MGI’s advanced gene sequencing platform, thereby advancing precision medicine in Brazil. The collaboration will focus on providing more accurate diagnoses in cancer and rare diseases, among other areas, leveraging MGI’s high-throughput sequencer DNBSEQ-T7 and lab automation products such as the MGISP-100 and MGISP-960, which are designed to enhance operational efficiency and reduce costs in Dasa’s laboratories. Financial details of the agreement were not disclosed.-Fineline Info & Tech